Erlotinib plus bevacizumab for EGFR-mutant advanced...

Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line?

Adderley, Helen, Ackermann, Christoph Jakob, Califano, Raffaele
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Journal:
Annals of Translational Medicine
DOI:
10.21037/atm.2019.09.116
Date:
December, 2019
File:
PDF, 162 KB
2019
Conversion to is in progress
Conversion to is failed